Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies

• Published in: Farmacia hospitalaria 2022-05, Vol.46 (3), p.109-115
• Main Authors: Montoro-Ronsano, José Bruno, Poveda-Andrés, José Luis, Romero-Garrido, José Antonio, Barrena, Blanca López-Chicheri, Vella, Vincenzo Alberto
• Format: Article
• Language: eng ; por ; spa
• Subjects: Atención farmacéutica; Calidad asistencial; Coagulopatías congénitas; Hereditary blood coagulation disorders; Hospital pharmacy department; Pharmaceutical care; Quality of healthcare; Servicio de farmacia hospitalaria
• ISSN: 1130-6343
• DOI: 10.7399/fh.11729

To identify and promote initiatives aimed at improving the management by hospital pharmacists of patients with congenital coagulopathies in the Spanish healthcare context. A series of initiatives to improve the care of patients with congenital coagulopathies were identified, evaluated, and prioritized by a panel of hospital pharmacists. Prioritization was based on an assessment of each initiative's impact and feasibility on a scale of 1 to 5. Once initiatives were prioritized, those assigned the highest priority were grouped into three action areas. Seven areas of activity were identified in which the role of hospital pharmacists is key for the management of patients with congenital coagulopathies: coordination with the healthcare team; drug evaluation and selection; dispensing; patient information and education; pharmacotherapeutic follow-up; research and innovation in the field of congenital coagulopathies; and capacity-building and training of hospital pharmacists. Fifteen initiatives were considered a priority, with an average impact score ≥ 3.8 and a feasibility score ≥ 3.2. A total of, 29.4% of the prioritized initiatives corresponded to healthcare, 23.5% to patient information and education, 11.8% to drug evaluation and selection, 11.8% to pharmacotherapeutic monitoring, 11.8% to cross-sectional initiatives, 5.9% to dispensing and 5.9% to research and innovation in the field of congenital coagulopathies: In contrast, initiatives related to capacity-building and training were not prioritized. Three main action areas were proposed based on the initiatives identified as high priority for the management of patients with congenital coagulopathies by a panel of 16 hospital pharmacists. Action areas revolved around specific activities that hospital pharmacy departments can undertake to contribute to improving the healthcare situation in Spain. Identificar e impulsar iniciativas orientadas a la mejora del manejo de los pacientes con coagulopatías congénitas por parte de farmacia hospitalaria en el contexto sanitario español. Se identificaron, evaluaron y priorizaron, por parte de un panel de farmacéuticos especialistas en farmacia hospitalaria, iniciativas para la mejora de la atención a los pacientes con coagulopatías congénitas. La priorización se realizó en base a la valoración de su impacto y factibilidad en una escala del 1 al 5. Una vez obtenida la priorización de las iniciativas, las de mayor puntuación se agruparon en tres grandes líneas de actuació